ADMA BIOLOGICS, INC. (ADMA) › Gross ProfitADMA BIOLOGICS, INC. (ADMA) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2011: $553.5K2012: $449.1K2013: $1.04M2014: $2.17M2015: $2.87M2016: $4.30M2017: -$6.40M2018: -$25.21M2020: -$19.07M2021: $1.17M2022: $35.27M2023: $88.94M2024: $219.55M2025: $292.76M$292.76M2011Gross Profit (USD)2025Fiscal YearGross ProfitChange YoY2025$292.76M+33.3%2024$219.55M+146.8%2023$88.94M+152.2%2022$35.27M+2906.4%2021$1.17M+106.2%2020-$19.07M—2018-$25.21M-293.7%2017-$6.40M-248.9%2016$4.30M+50.0%2015$2.87M+31.9%2014$2.17M+108.1%2013$1.04M+132.5%2012$449.1K-18.9%2011$553.5K—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share